Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.
Bengala C, Bertolini F, Malavasi N, Boni C, Aitini E, Dealis C, Zironi S, Depenni R, Fontana A, Del Giovane C, Luppi G, Conte P. Bengala C, et al. Among authors: dealis c. Br J Cancer. 2010 Jan 5;102(1):68-72. doi: 10.1038/sj.bjc.6605458. Epub 2009 Nov 24. Br J Cancer. 2010. PMID: 19935794 Free PMC article. Clinical Trial.
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.
Bengala C, Bettelli S, Bertolini F, Salvi S, Chiara S, Sonaglio C, Losi L, Bigiani N, Sartori G, Dealis C, Malavasi N, D'Amico R, Luppi G, Gatteschi B, Maiorana A, Conte PF. Bengala C, et al. Among authors: dealis c. Ann Oncol. 2009 Mar;20(3):469-74. doi: 10.1093/annonc/mdn647. Epub 2008 Dec 18. Ann Oncol. 2009. PMID: 19095777 Free article.
Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF. Bertolini F, et al. Among authors: dealis c. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1455-61. doi: 10.1016/j.ijrobp.2007.02.018. Epub 2007 Apr 18. Int J Radiat Oncol Biol Phys. 2007. PMID: 17445998
Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.
Bertolini F, Chiara S, Bengala C, Antognoni P, Dealis C, Zironi S, Malavasi N, Scolaro T, Depenni R, Jovic G, Sonaglio C, Rossi A, Luppi G, Conte PF. Bertolini F, et al. Among authors: dealis c. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):466-72. doi: 10.1016/j.ijrobp.2008.04.065. Epub 2008 Nov 10. Int J Radiat Oncol Biol Phys. 2009. PMID: 19004567 Clinical Trial.
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
Rudà R, Pellerino A, Pace A, Carapella CM, Dealis C, Caroli M, Faedi M, Bello L, Migliore E, Marchese G, Bertero L, Cassoni P, Soffietti R. Rudà R, et al. Among authors: dealis c. J Neurooncol. 2019 Oct;145(1):115-123. doi: 10.1007/s11060-019-03277-x. Epub 2019 Sep 25. J Neurooncol. 2019. PMID: 31556015 Free article. Clinical Trial.
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016.
Rudà R, Pellerino A, Pace A, Carapella CM, Dealis C, Caroli M, Faedi M, Bello L, Migliore E, Marchese G, Bertero L, Cassoni P, Soffietti R. Rudà R, et al. Among authors: dealis c. J Neurooncol. 2019 Dec;145(3):593. doi: 10.1007/s11060-019-03331-8. J Neurooncol. 2019. PMID: 31691059
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge.
Passarin MG, Sava T, Furlanetto J, Molino A, Nortilli R, Musso AM, Zaninelli M, Franceschi T, Orrico D, Marangoni S, Dealis C, Graiff C, Filippo R, Grisanti S, Simoncini E, Vassalli L, Berruti A, Pedersini R. Passarin MG, et al. Among authors: dealis c. Neurol Sci. 2015 Jan;36(1):117-23. doi: 10.1007/s10072-014-1881-7. Epub 2014 Jul 16. Neurol Sci. 2015. PMID: 25022241
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
Caccese M, Desideri I, Villani V, Simonelli M, Buglione M, Chiesa S, Franceschi E, Gaviani P, Stasi I, Caserta C, Brugnara S, Lolli I, Bennicelli E, Bini P, Cuccu AS, Scoccianti S, Padovan M, Gori S, Bonetti A, Giordano P, Pellerino A, Gregucci F, Riva N, Cinieri S, Internò V, Santoni M, Pernice G, Dealis C, Stievano L, Paiar F, Magni G, De Salvo GL, Zagonel V, Lombardi G. Caccese M, et al. Among authors: dealis c. ESMO Open. 2024 Apr;9(4):102943. doi: 10.1016/j.esmoop.2024.102943. Epub 2024 Mar 15. ESMO Open. 2024. PMID: 38492275 Free PMC article.